avalglucosidase alfa
Alimentary tract and metabolism (A16)Alimentary tract and metabolism (A16) compound in Sanofi Winthrop Industrie's portfolio. Molecular target: Glycogen.
- Target
- Glycogen
- Mechanism
- Glycogen hydrolytic enzyme
pharma · Glycogen storage disease type II · Niemann-Pick disease
Sanofi Winthrop Industrie
Sanofi Winthrop Industrie drug portfolio — 6 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
ANTONY, FR HQ
12 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- ANTONY, FR
- Employees
- 12
- Programs
- 2
- Drugs
- 6
- Patents
- 0
Sanofi Winthrop Industrie pipeline
Portfolio lens on 6 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Sanofi Winthrop Industrie drug portfolio — 6 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
US regulatory status: approved. Molecular target: Estrogen receptor.
- Target
- Estrogen receptor
- Mechanism
- Estrogen receptor alpha agonist
-
Development asset linked to Sanofi Winthrop Industrie in public FDA and regional records.
-
olipudase alfa
Alimentary tract and metabolism (A16)Alimentary tract and metabolism (A16) compound in Sanofi Winthrop Industrie's portfolio. Molecular target: Sphingomyelin.
- Target
- Sphingomyelin
- Mechanism
- Sphingomyelin hydrolytic enzyme
-
Development asset linked to Sanofi Winthrop Industrie in public FDA and regional records.
-
Development asset linked to Sanofi Winthrop Industrie in public FDA and regional records.